737 related articles for article (PubMed ID: 7500015)
21. CDR3α drives selection of the immunodominant Epstein Barr virus (EBV) BRLF1-specific CD8 T cell receptor repertoire in primary infection.
Kamga L; Gil A; Song I; Brody R; Ghersi D; Aslan N; Stern LJ; Selin LK; Luzuriaga K
PLoS Pathog; 2019 Nov; 15(11):e1008122. PubMed ID: 31765434
[TBL] [Abstract][Full Text] [Related]
22. CTL recognition of a bulged viral peptide involves biased TCR selection.
Miles JJ; Elhassen D; Borg NA; Silins SL; Tynan FE; Burrows JM; Purcell AW; Kjer-Nielsen L; Rossjohn J; Burrows SR; McCluskey J
J Immunol; 2005 Sep; 175(6):3826-34. PubMed ID: 16148129
[TBL] [Abstract][Full Text] [Related]
23. H-2-restricted cytolytic T lymphocytes specific for HLA display T cell receptors of limited diversity.
Casanova JL; Cerottini JC; Matthes M; Necker A; Gournier H; Barra C; Widmann C; MacDonald HR; Lemonnier F; Malissen B; Maryanski JL
J Exp Med; 1992 Aug; 176(2):439-47. PubMed ID: 1380061
[TBL] [Abstract][Full Text] [Related]
24. Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment.
Lehner PJ; Wang EC; Moss PA; Williams S; Platt K; Friedman SM; Bell JI; Borysiewicz LK
J Exp Med; 1995 Jan; 181(1):79-91. PubMed ID: 7807026
[TBL] [Abstract][Full Text] [Related]
25. T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant.
Kalams SA; Johnson RP; Dynan MJ; Hartman KE; Harrer T; Harrer E; Trocha AK; Blattner WA; Buchbinder SP; Walker BD
J Exp Med; 1996 Apr; 183(4):1669-79. PubMed ID: 8666925
[TBL] [Abstract][Full Text] [Related]
26. Genetic and structural basis for selection of a ubiquitous T cell receptor deployed in Epstein-Barr virus infection.
Miles JJ; Bulek AM; Cole DK; Gostick E; Schauenburg AJ; Dolton G; Venturi V; Davenport MP; Tan MP; Burrows SR; Wooldridge L; Price DA; Rizkallah PJ; Sewell AK
PLoS Pathog; 2010 Nov; 6(11):e1001198. PubMed ID: 21124993
[TBL] [Abstract][Full Text] [Related]
27. Changing patterns of dominant TCR usage with maturation of an EBV-specific cytotoxic T cell response.
Annels NE; Callan MF; Tan L; Rickinson AB
J Immunol; 2000 Nov; 165(9):4831-41. PubMed ID: 11046006
[TBL] [Abstract][Full Text] [Related]
28. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
[TBL] [Abstract][Full Text] [Related]
29. The clonal composition of a peptide-specific oligoclonal CTL repertoire selected in response to persistent EBV infection is stable over time.
Levitsky V; de Campos-Lima PO; Frisan T; Masucci MG
J Immunol; 1998 Jul; 161(2):594-601. PubMed ID: 9670932
[TBL] [Abstract][Full Text] [Related]
30. Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.
Khanna R; Burrows SR; Steigerwald-Mullen PM; Thomson SA; Kurilla MG; Moss DJ
Virology; 1995 Dec; 214(2):633-7. PubMed ID: 8553567
[TBL] [Abstract][Full Text] [Related]
31. New tools to monitor the impact of viral infection on the alloreactive T-cell repertoire.
D'Orsogna LJ; Amir AL; Zoet YM; van der Meer-Prins PM; van der Slik AR; Kester MG; Heemskerk MH; Doxiadis II; Roelen DL; Claas FH
Tissue Antigens; 2009 Oct; 74(4):290-7. PubMed ID: 19624615
[TBL] [Abstract][Full Text] [Related]
32. The structure of HLA-B8 complexed to an immunodominant viral determinant: peptide-induced conformational changes and a mode of MHC class I dimerization.
Kjer-Nielsen L; Clements CS; Brooks AG; Purcell AW; Fontes MR; McCluskey J; Rossjohn J
J Immunol; 2002 Nov; 169(9):5153-60. PubMed ID: 12391232
[TBL] [Abstract][Full Text] [Related]
33. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide.
Brooks JM; Murray RJ; Thomas WA; Kurilla MG; Rickinson AB
J Exp Med; 1993 Sep; 178(3):879-87. PubMed ID: 7688791
[TBL] [Abstract][Full Text] [Related]
34. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response.
Steven NM; Annels NE; Kumar A; Leese AM; Kurilla MG; Rickinson AB
J Exp Med; 1997 May; 185(9):1605-17. PubMed ID: 9151898
[TBL] [Abstract][Full Text] [Related]
35. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR
J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422
[TBL] [Abstract][Full Text] [Related]
36. Biased T cell receptor usage by Ld-restricted, tum- peptide-specific cytotoxic T lymphocyte clones.
Solheim JC; Alexander-Miller MA; Martinko JM; Connolly JM
J Immunol; 1993 Feb; 150(3):800-11. PubMed ID: 8380825
[TBL] [Abstract][Full Text] [Related]
37. Restricted V-segment usage in T-cell receptors from cytotoxic T lymphocytes specific for a major epitope of lymphocytic choriomeningitis virus.
Yanagi Y; Maekawa R; Cook T; Kanagawa O; Oldstone MB
J Virol; 1990 Dec; 64(12):5919-26. PubMed ID: 1700830
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr Virus Epitope-Major Histocompatibility Complex Interaction Combined with Convergent Recombination Drives Selection of Diverse T Cell Receptor α and β Repertoires.
Gil A; Kamga L; Chirravuri-Venkata R; Aslan N; Clark F; Ghersi D; Luzuriaga K; Selin LK
mBio; 2020 Mar; 11(2):. PubMed ID: 32184241
[TBL] [Abstract][Full Text] [Related]
39. The shaping of T cell receptor recognition by self-tolerance.
Gras S; Burrows SR; Kjer-Nielsen L; Clements CS; Liu YC; Sullivan LC; Bell MJ; Brooks AG; Purcell AW; McCluskey J; Rossjohn J
Immunity; 2009 Feb; 30(2):193-203. PubMed ID: 19167249
[TBL] [Abstract][Full Text] [Related]
40. Dominant cytotoxic T lymphocyte response to the immediate-early trans-activator protein, BZLF1, in persistent type A or B Epstein-Barr virus infection.
Elliott SL; Pye SJ; Schmidt C; Cross SM; Silins SL; Misko IS
J Infect Dis; 1997 Oct; 176(4):1068-72. PubMed ID: 9333169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
